News + Filings Transactions
|
McKelligon Brian
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 5k | $5.71 | $28.5k | | 06/06/2023 |
| 06/06/2023 | Akoya Biosciences, Inc. | AKYA | Exercise | Employee Stock Option (Right to Buy) | 5k | $0.30 | $1.5k | | 06/06/2023 |
| 03/23/2023 | Akoya Biosciences, Inc. | AKYA | Payment of Exercise | Common Stock | 7.4k | $7.69 | $57.2k | | 03/23/2023 |
| 03/14/2023 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 4.8k | $9.14 | $43.6k | | 03/14/2023 |
| 03/14/2023 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 226 | $9.92 | $2.2k | | 03/14/2023 |
| 03/14/2023 | Akoya Biosciences, Inc. | AKYA | Exercise | Employee Stock Option (Right to Buy) | 5k | $0.30 | $1.5k | | 03/14/2023 |
| 02/23/2023 | Akoya Biosciences, Inc. | AKYA | Grant | Common Stock | 80k | $0.00 | $0 | | 02/23/2023 |
| 02/23/2023 | Akoya Biosciences, Inc. | AKYA | Grant | Employee Stock Option (Right to Buy) | 160k | $12.30 | $2M | | 02/23/2023 |
| 12/06/2022 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 5k | $12.08 | $60.4k | | 12/06/2022 |
| 12/06/2022 | Akoya Biosciences, Inc. | AKYA | Exercise | Employee Stock Option (Right to Buy) | 5k | $0.30 | $1.5k | | 12/06/2022 |
| 09/07/2022 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 5k | $12.83 | $64.2k | | 09/07/2022 |
| 09/07/2022 | Akoya Biosciences, Inc. | AKYA | Exercise | Employee Stock Option (Right to Buy) | 5k | $0.30 | $1.5k | | 09/07/2022 |
| 06/15/2022 | Akoya Biosciences, Inc. | AKYA | Sale | Common Stock | 5k | $10.25 | $51.3k | | 06/15/2022 |
| 06/15/2022 | Akoya Biosciences, Inc. | AKYA | Exercise | Employee Stock Option (Right to Buy) | 5k | $0.30 | $1.5k | | 06/15/2022 |
| 03/23/2022 | Akoya Biosciences, Inc. | AKYA | Grant | Common Stock | 80k | $0.00 | $0 | | 03/23/2022 |
| 03/23/2022 | Akoya Biosciences, Inc. | AKYA | Grant | Employee Stock Option (Right to Buy) | 160k | $11.88 | $1.9M | | 03/23/2022 |
|